Key Dates

Related Announcements

PAR-19-301 - Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The National Institute of General Medical Sciences (NIGMS) issued PAR-19-301 "Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)" to encourage applications for support of national or regional resources that will provide access to state-of-the-art facilities, equipment, technologies, research tools, software, and/or service to a substantial user base at institutions across multiple states (regional) or the country (national).

The purpose of this Notice is to clarify that technologies that are broadly available at individual institutions and those already supported by national or regional centers and resources (e.g., NMR spectroscopy, mass spectrometry, cryo-EM, and cryo-ET) are currently a low priority for this R24 program.

Inquiries

Please direct all inquiries to:

Christina Liu, PhD,PE
National Institute of General Medical Sciences (NIGMS)
Division of Biophysics, Biomedical Technology, and Computational Biosciences (BBCB)
Email: christina.liu@nih.gov